CHARLOTTESVILLE, Virginia, June 17 -- The University of Virginia issued the following Q&A on June 16, 2026, involving Matthew Reilley, associate professor of medicine in the School of Medicine and director of UVA Health's gastrointestinal medical oncology research program:

* * *

Q&A: What does the new 'game-changer' pill offer pancreatic cancer patients?

By Jane Kelly, jak4g@virginia.edu

A new drug for pancreatic cancer . . .

Click here for more information about our products